Although schwannomin, the product of the neurofibromatosis type 2 gene, shares homology with three cytoskeleton-to-membrane protein linkers defining the ERM family, the mechanism by which it exerts a tumor suppressive activity remains elusive. Based on the knowledge of naturally occurring mutations, a functional study of schwannomin was initiated. Constructs encoding the two wild-type isoforms and nine mutant forms were transfected into HeLa cells. Transiently 
INTRODUCTION
Neurofibromatosis type 2 (NF2) is an autosomal dominantly inherited disease which predisposes to the development of nervous system tumors, mainly bilateral vestibular schwannomas and to a lesser extent schwannomas affecting spinal nerve roots, meningiomas and ependymomas (1) . The NF2 gene which when mutated causes this predisposition was identified in 1993 (2, 3) . Both alleles of the NF2 gene were observed mutated in tumors of NF2 patients (2-9) but also in sporadically occurring schwannomas and meningiomas (2, 3, 10, 11) , strongly suggesting that the NF2 gene has a tumor suppressive activity. In accord with this hypothesis, transfection of wild-type NF2 cDNA was shown to decrease the growth rate of NIH3T3 cells (12) , and to revert their ras-induced malignant phenotype (13) .
The NF2 gene product, designated either 'schwannomin' (2) or 'merlin' (3) is a 595 amino acid protein that exhibits homologies with ezrin, radixin and moesin, a group of three closely related proteins collectively termed the ERM family (14) . This family is part of the band 4.1 superfamily, which also includes band 4.1 protein, talin and several tyrosine phosphatases (15) . Some members of this superfamily have been shown to act as linkers between the plasma membrane and cytoskeletal structures. More specifically, ERM proteins reportedly colocalize with the cell surface proteins CD43, CD44, ICAM-2 (16) (17) (18) and possibly ICAM-1 (18) . In addition, Hirao et al. (19) demonstrated that the N-terminal region of the ERM proteins interacts with CD44 and that Rho may be involved in the regulation of this interaction.
Furthermore, the 34 most C-terminal amino acids of ezrin and moesin, which are highly conserved among the three ERM proteins, have been shown to contain an actin-binding site (20, 21) .
The amino acid sequence of schwannomin reveals structural similarities with the ERM proteins: the N-terminal domain, that spans amino acids 1-314, shares 61-63% identity with the equivalent domain of each of the three ERM members. This domain has no obvious secondary structure. The C-terminal half of schwannomin (from amino acid 315 to 595) and those of the three ERM proteins are predicted to adopt mostly an alpha helical conformation. In the case of schwannomin, ezrin and radixin, this α-helix is interrupted by a proline rich sequence. Schwannomin has recently been reported to localize underneath the plasma membrane and to co-distribute with elements of the cytoskeleton in smooth muscle cells (22) and in Schwann cells (23) . In fibroblasts and meningioma cells it has been shown to concentrate preferentially in membrane ruffles (24) . Similar locations have been observed for members of the ERM family (14) . The inhibition of NF2 gene expression in cultured cells by an antisense oligonucleotide strategy causes a decrease in cell adhesion that resembles that induced by the concomitant inhibition of the synthesis of all three ERM proteins (25) . Taken together, these observations would suggest that schwannomin may share with the ERM family a role in the association of the cytoskeleton with the plasma membrane.
Schwannomin appears, however, significantly different from the ERM proteins. The latter proteins share 85% identity in their N-terminal domains, while the corresponding domain of schwannomin appears more distantly related. In contrast to the ERM proteins, schwannomin has two major isoforms which differ at their C-terminal end (26) . Neither C-terminal ends of these isoforms demonstrate homology with the highly conserved 34 amino acid actin-binding domain identified at the C-terminus of the ERM proteins. At present, no direct experimental evidence supporting an interaction of schwannomin with cytoskeletal elements or characterized membrane components has yet been provided.
The NF2 gene, in contrast to the ERM-related genes, undergoes frequent biallelic inactivation in human tumor types, specifically in schwannomas, meningiomas and mesotheliomas (2, 3, 10, 11, 27, 28) . Extensive mutational analyses have been performed on NF2 patients and on sporadic tumors. The majority of the mutations of the NF2 gene consists of nonsense, frameshift or splice-site mutations that result in the truncation of the gene product (2, 3, (5) (6) (7) (8) (9) (10) (11) . However, a small number of mutations such as missense mutations, in frame interstitial deletions in exons or splice-site mutations causing exon skipping without frameshift, have been identified. We have taken advantage of the knowledge of such mutations to initiate the delineation of domains of interaction for schwannomin by examining the localization and detergent solubility of transiently expressed normal and mutant forms of schwannomin in intact HeLa cells or in HeLa cells with altered cytoskeleton.
RESULTS

Expression of wild-type and mutant schwannomin proteins
In order to transiently express either isoforms of schwannomin, the corresponding cDNAs were placed under the control of the cytomegalovirus promoter of the pCB6 eukaryotic expression vector (Fig. 1) . In both cases, two different constructs were generated that led either to the natural C-terminal end (Sch-Iso1 and Sch-Iso2) or to the linking of an epitope derived from the vesicular stomatitis virus glycoprotein G (VSV-G) (Sch-Iso1-Tag Figure 1 . Schematic representation of the structural domains of schwannomin, description of the different cDNA constructs used in the study and summary of the properties of the corresponding proteins. (A) Model of the predicted structural organization of schwannomin determined from its primary sequence (2, 3) and by homology with the ERM family members (15) . The successive boxes correspond to the different structural motifs of the protein. The numbers refer to the amino acid positions (2) . The N-terminal domain (white rectangle) is followed by the α-helical structures (black rectangle) interrupted by the proline rich region as indicated (P). (B) Detail of the various cDNA constructs. With the exception of the three constructs encoding truncated schwannomins, Sch-T1, Sch-T2 and Sch-T3, all constructs were performed under two versions which encoded either the natural C-terminal end or a VSV-G tagged C-terminal end. Both versions were systematically subjected to the same tests for localization, cytochalasin D induced relocalization and detergent extractibility. In all tests, proteins expressed from either version always provided identical results. Thick lines indicate the regions of schwannomin that are present in the encoded protein. The white and black squares at the C-terminal end correspond to the specific sequences of isoforms 1 and 2, respectively. The positions of amino acid substitutions or deletions are indicated by arrows. On the right, the properties of the various proteins are summarized. Mb, submembraneous localization; PN, formation of perinuclear aggregates.
and Sch-Iso2-Tag). This procedure was followed in order to enable the detection of the plasmid-encoded proteins in transfected cells and their discrimination from endogenous proteins including ERM members and schwannomin.
As most mutations described in NF2 patients or sporadic tumors are predicted to cause protein truncation at various positions along the sequence, three different constructs removing the last 70, 89 and 120 amino acids of schwannomin were created. Sch-T1 results in the loss of the region encoded by the two last exons of the NF2 gene, exons 15 and 16 (amino acids 526-595). Such a truncation is predicted to have occurred in three unrelated NF2 patients with a germline mutation at the splice-acceptor site of exon 15 (6, 8, 9) . It is one of the most C-terminal mutations that has yet been described. Sch-T2 is deleted of the most C-terminal α-helix that is distal to the proline rich structure. The latter region has been removed in the Sch-T3 mutant (see Fig. 1 ). Sch-T2 and Sch-T3 are 506 and 475 amino acids long, respectively, and resemble several naturally occurring mutant proteins predicted to be 514, 513 and 493 amino acids long (5, (8) (9) (10) or 484, 470, 466 and 463 amino acids long (5) (6) (7) 9, 11) .
Several DNA variants leading to single amino acid substitutions have been identified in NF2 patients and related tumors. Three constructs encoding schwannomin with a single amino acid change, Sch-219, Sch-220 and Sch-360, were derived from the Sch-Iso1 plasmid (Fig. 1) . The same mutations were also introduced in the Sch-Iso1-Tag plasmid. The mutation at position 219 (Val→Met) has been reported in a sporadic meningioma (11) and represents also a second hit in a schwannoma from an NF2 patient (10) . The mutation at position 220 (Asn→Tyr) was observed in affected members of two independent NF2 kindreds (4, 8) . Finally, the mutation at position 360 (Leu→Pro) was detected in constitutional DNA from affected individuals of an NF2 family (8) , and from two presumably unrelated NF2 patients (6, 29) .
Several mutations found in NF2 patients are predicted to lead to interstitial deletion in the mutant protein. A number of such mutations were introduced into the Sch-Iso1 and Sch-Iso1-Tag constructs. Two constructs (Sch-∆118 and Sch-∆118-Tag) were generated that correspond to the in-frame deletion of one of the two phenylalanine residues located at positions 118-119, a deletion that was observed in two unrelated NF2 patients (7, 29) and in one sporadic meningioma (11) . Splicing out of one or several exons when not resulting in a frameshift may cause interstitial deletion in schwannomin. This hypothesis was verified in the case of patient GL9 (6) . Sequencing of the RT-PCR product derived from RNAs extracted from a lymphoblastoid cell line of this patient demonstrated the skipping of exons 2 and 3 (P. Mérel, unpublished data). The corresponding transcript encodes a protein that is deleted of amino acids 39-121. Two constructs encoding such a mutant protein were generated [Sch-∆(39-121) and Sch-∆(39-121)-Tag]. Finally, in order to document the specific role of the C-terminal domain of schwannomin, two constructs called Sch-∆Nter and Sch-∆Nter-Tag were also derived from the plasmid encoding wild-type isoform 1 of schwannomin. These last two constructs do not correspond closely to previously reported natural mutation.
Each member of couples of constructs that encoded proteins which differed only by the presence or absence of the VSV-G tag were systematically subjected to the same tests for localization and detergent extractibility. On every occasion both members of the same couple provided identical results.
Expression of all constructs was tested by immunoblotting ( Fig. 2) . When the construct contained the VSV-G tag, a monoclonal anti-tag was used. On each occasion a single band was observed. Wild-type schwannomin isoforms 1 and 2, and mutants Sch-219, Sch-220, Sch-360 and Sch-∆118, all had an apparent molecular weight of ∼80 kDa (Fig. 2 ). This is ∼8 kDa larger than expected. The same abnormal electrophoretic migration was also observed for Sch-∆(39-121) and Sch-∆Nter. A similar shift in mobility has been documented for full-length ezrin and for its C-terminal domain (30) and is likely due to the proline stretch. When untagged constructs were transfected, a commercially available polyclonal antibody directed against the first 20 amino acids of schwannomin (polyclonal anti-Nter antibody) was used. We verified that this antibody did not crossreact with any of the ERM proteins by immunoblotting (data not shown). With this antibody, all transfected cell extracts exhibited, in addition to the exogenously expressed protein, a protein doublet of ∼80 kDa that may correspond to the two endogenous schwannomin isoforms or to forms with different phosphorylation status, or to other proteins (Fig. 2B) . Again the mobility of all expressed proteins was slower than expected leading to a molecular mass that was overestimated by 5-8 kDa.
Subcellular distribution
Schwannomin isoforms 1 and 2. Immunofluorescence staining with polyclonal anti-Nter antibody or monoclonal anti-tag of HeLa cells transiently transfected with Sch-Iso1 or Sch-Iso1-Tag indicated that schwannomin isoform 1 was predominantly distributed underneath the plasma membrane (Fig. 3A) , a location that has been reported for schwannomin in COS cells (22) . When double fluorescence staining with the anti-tag antibody and phalloidin was performed, schwannomin isoform 1 appeared concentrated in F-actin-rich membrane protrusions such as membrane ruffles, microspikes and filopodia ( Fig. 3A and B) . Schwannomin was not detected associated with actin stress fibers. Overproduction of schwannomin did not induce evident modification of actin-containing structures (Fig. 3B) . Confocal microscopy analysis of transfected HeLa cells confirmed these findings and indicated a prominent distribution of schwannomin at the cortex. Cells transfected with a construct encoding schwannomin isoform 2 presented an identical distribution for the transiently expressed protein. The same submembranous localization was also observed in the pig kidney epithelial cell line LLC-PK1, in the monkey kidney fibroblast-like cell line CV-1 or in cell lines derived from a rat schwannoma (RN22, a kind gift from D. Lowy) or from a human meningioma (SF1335, kindly provided by S. Rempel) (data not shown).
Mutant forms of schwannomin. HeLa cells were transfected with cDNAs encoding the three C-terminally truncated proteins, and localization of the mutant proteins was analyzed by double fluorescence labeling with the polyclonal anti-Nter antibody in the presence of fluorescent phalloidin. All tested truncated forms of schwannomin had a pattern of expression similar to that observed with wild-type schwannomin. The same observation was made with the three missense mutant proteins.
In sharp contrast, when HeLa cells were transfected with the constructs encoding mutant schwannomin deleted of a single phenylalanine residue in position 118 (Sch-∆118 or Sch-∆118-Tag), the mutant proteins were no longer restricted to the plasma membrane but distributed widely in the cytoplasm giving rise to punctuated structures which tended to gather around the nucleus (Fig. 3C) . The deletion of the 83 residues (residues 39-121) encoded by the exons 2 and 3 of the NF2 gene [construct Sch-∆(39-121) or Sch-∆(39-121)-Tag] led to an identical distribution of the proteins. In both cases, the overproduction of the mutant proteins did not appear to affect the distribution of stress fibers (Fig. 3D ). Immunostaining performed on HeLa cells transfected with the constructs encoding schwannomin deleted of its entire N-terminal domain (Sch-∆Nter or Sch-∆Nter-Tag) revealed aggregates surrounding the nucleus. These structures were larger than those observed when expressing Sch-∆118 or Sch-∆(39-121) (Fig. 3E) . In most of the transfected cells, the nucleus shape was affected and appeared convoluted. Double fluorescence labeling with an anti-lamin B antibody did not show any association of the aggregates with the nuclear membrane (data not shown). The mutant protein did not colocalize with F-actin structures which were not reorganized by the mutant schwannomin overproduction (Fig. 3F) . The LLC-PK1, CV-1, RN22 and SF1335 cell lines revealed the same pattern of distribution for the transiently expressed Sch-∆Nter or Sch-∆Nter-Tag proteins. Cells transfected with a construct encoding the C-terminal part of schwannomin isoform 2 demonstrated the same behavior.
The peculiar structures generated by the expression of proteins Sch-∆118, Sch-∆(39-121) and Sch-∆Nter prompted us to check whether the mutant proteins were associated with organelles. Antibodies that specifically stain different endocytic compartments (antibodies directed against lgp120, a lysosomal protein, antibodies against transferrin receptor and mannose 6-phosphate receptor, or antibodies that recognize specifically the endoplasmic reticulum or the Golgi apparatus) did not colocalize with the mutant schwannomins (data not shown). Electron microscopy analysis of the structures generated by the expression of proteins Sch-∆118, Sch-∆(39-121) or Sch-∆Nter failed to reveal surrounding membranes, thus confirming that these structures were not associated with specific compartments (Fig. 4) .
Detergent extractability of schwannomin isoforms 1 and 2 and of mutant schwannomins
A possible interaction of schwannomin with cytoskeletal elements was investigated by performing cell fractionation assays as described by Algrain et al. (30) . It is established that this detergent extraction procedure preserves the cytoskeleton and maintains tightly linked proteins in the insoluble fraction. The detergent insolubility of such proteins can be visualized by immunofluorescence labeling after extraction or by immunoblot analysis of equal amounts of the extracted and the non-extracted fractions. HeLa cells were transfected with Sch-Iso1 or Sch-Iso1-Tag and detergent extracted. Immunostaining revealed neither a change in the distribution nor a major decrease in intracellular concentration of schwannomin isoform 1, suggesting that this protein stably interacts with cytoskeletal components. This hypothesis was confirmed when cell fractionation indicated that schwannomin was absent from the soluble fraction (Fig. 5) . Double fluorescence labeling showed that schwannomin was not associated with actin stress fibers after extraction. The same conclusion was reached for schwannomin isoform 2 (Fig. 5A) . In contrast, the truncated proteins encoded by Sch-T1, Sch-T2 and Sch-T3 were in part detergent extractable (Fig. 5B) . Detergent extraction was also performed on cells transfected with constructs encoding missense mutant proteins. Fluorescence labeling with the anti-tag antibody revealed that the protein mutated at amino acid 360 was also detergent extractable. This observation was confirmed by immunoblotting (Fig. 5A ). Immunofluorescence staining of cells expressing proteins Sch-∆118, Sch-∆(39-121) or Sch-∆Nter after detergent extraction showed that the staining pattern and intensity remained unaltered. Immunoblotting confirmed that these three mutant proteins were detergent insoluble (Fig. 5A ).
Cytochalasin D treatment
To further characterize the interaction of schwannomin with cytoskeletal elements, cells overproducing schwannomin isoform 1 were treated with cytochalasin D, an agent that specifically disorganizes actin cytoskeletal structures. Double fluorescence labeling showed that full-length schwannomin co-distributed with the induced patches of actin (Fig. 6) . Confocal microcopy analysis of the treated cells confirmed that schwannomin was relocalized in the periphery of the actin foci. Disruption of actin filaments by cytochalasin D led to a similar redistribution of the C-terminally truncated proteins encoded by constructs Sch-T1, Sch-T2 and Sch-T3 and of all missense mutant proteins. In contrast, cytochalasin D treatment of cells expressing Sch-∆118, Sch-∆(39-121) or Sch-∆Nter did not affect the perinuclear distribution of these mutant proteins.
Search for interaction with other cytoskeletal components
Double staining of isoform 1 and of either tubulin, vimentin or keratins failed to reveal colocalization of schwannomin with microtubules or intermediate filaments. Similarly, Sch-∆118 or Sch-∆Nter were not found to colocalize with these cytoskeletal components. Treatment of cells with nocodazole, a microtubuledisrupting agent, did not modify the cellular distribution of schwannomin isoform 1, Sch-∆118 or Sch-∆Nter (data not shown). 
DISCUSSION
ERM proteins have been shown to interact with the actin cytoskeleton (20, 21) . Owing to its homology with the ERM proteins, the colocalization of Schwannomin with cortical actin in several cell types was not unexpected (22) (23) (24) . In order to document further the putative association of schwannomin with cytoskeletal components, transfected cells were extracted with Triton X-100, under conditions that preserve the cytoskeletal structure. Schwannomin was not extracted by this biochemical fractionation procedure. With the possible exception of smooth muscle cells (22) , schwannomin was not found associated with actin stress fibers (23, 24 , this work). In contrast, exposure of the transiently transfected cells to cytochalasin D, which dissociates actin filaments, caused a marked change in the localization of schwannomin. Taken together these observations suggest that, in most cell types, schwannomin should interact with cortical F-actin either directly or indirectly. Interestingly, it has been shown that the 34 C-terminal amino acids of ezrin and moesin contain an F-actin-binding site (20, 21) . This region is highly conserved in all three ERM proteins but is markedly different in those observed in either isoforms of schwannomin. Thus even though schwannomin may share with the ERM proteins a similar localization, it may not have the same modes of interaction with the cytoskeleton.
Various mutant schwannomins were investigated for their interaction with the cytoskeleton. In contrast to the C-terminal domain of ezrin which colocalizes with F-actin (30), Sch-∆Nter forms, at the periphery of the nucleus, non-vesicular aggregated structures which involve neither the actin nor the microtubule networks. This observation suggests that by itself the C-terminal domain of schwannomin does not form a stable interaction with the cytoskeleton. These aggregates may result from the formation of single or multicomponent structures or from local precipitation. As shown by the extraction experiments, these aggregates are stable even in the presence of non-ionic detergent. At least two subregions of this C-terminal domain may nonetheless contribute to the interaction of the intact protein with cytoskeletal components. Indeed, the removal of the last 70 amino acids or a single amino acid substitution at position 360 had the same phenotypic consequence: the mutant proteins remained in their normal submembranous location but exhibited a markedly increased detergent solubility. As shown by the cytochalasin D induced relocalization, these proteins maintained their interaction with the actin dependent structures. Such an interaction is not dependent on the presence of the polyproline rich region since identical properties were observed with a truncated protein that lacked this region. It may be suggested from these results that while the C-terminal domain of schwannomin is not sufficient to establish an interaction with cytoskeletal components by itself, it may contribute to stabilize such interaction in the intact schwannomin.
In vitro, the N-terminal domain of ERM proteins binds to the cytoplasmic region of CD44 (19) . Although to date this interaction has not been reported for schwannomin, the homology of the N-terminal domain of schwannomin with that of the ERM proteins suggests that this domain may also be involved in binding to membrane protein(s). In accord with this hypothesis, mutations resulting in the deletion of a part or of the entire N-terminal domain of schwannomin were observed to cause a relocalization of the protein from the membrane to the periphery of the nucleus. More strikingly, a single deletion of one of two adjacent phenylalanines at position 118-119 had a similar effect, pointing to a critical amino acid doublet for the submembraneous localization. Interestingly, this doublet is conserved in mouse and Drosophila schwannomin and in the three ERM proteins.
Most mutations studied here are similar or identical to mutations that had occurred at the germline level in NF2 patients or at the somatic level in NF2 related tumors. They are therefore likely to impair the tumor suppressor activity of the encoded protein. With two exceptions, all mutant schwannomin studied here were affected in their ability to establish a stable interaction with actin based cytoskeletal structures. This was notable for the various C-terminally deleted proteins studied which may be taken as models for most naturally occurring mutant proteins. It is anticipated that decrease in the stability of this interaction would impair tumor suppressor activity. If this prediction were confirmed, this observation would provide the basis of a functional test to document the defective nature of new alleles observed in NF2 patients or in tumors.
However, demonstration by this assay of an unaltered interaction potential is not sufficient to infer that the tested protein has maintained its full tumor suppressor function. Indeed, two missense mutant proteins (Val219Met and Asn220Tyr) could not be distinguished from the wild-type protein in this test. Nonetheless it is likely that these two mutations are deleterious. The mutations, Val219Met and Asn220Tyr, were each independently reported twice, the former occurred at the somatic level (10, 11) , the latter at the germline level (4, 8) . In both cases the relevant amino acid positions are conserved in mouse and Drosophila schwannomin. Both positions also demonstrate high conservation with the corresponding positions of the ERM proteins. In one case, the Asn220Tyr mutation, the mutated allele was observed to cosegregate with the disease in the two corresponding unrelated NF2 families (4, 8) . Taken together, these observations strongly indicate that the region defined by the two mutations at adjacent positions (219 and 220) is likely to be critical for the tumor suppressive function of schwannomin. Further advances in the knowledge of the structure and function of schwannomin is mandatory to provide a detailed mechanism by which these mutations may impair tumor suppressor function.
MATERIALS AND METHODS
Cell culture
HeLa cells were grown in Dulbecco's minimum essential medium (Gibco) supplemented with 10% fetal calf serum (Dutscher) and antibiotics, at 37_C, under a humidified 5% CO 2 atmosphere.
Antibodies
The monoclonal antibody P5D4, raised against the 11-amino acid C-terminus of VSV-G, was purchased from Sigma. The affinity purified polyclonal antibody A19 (polyclonal anti-Nter), raised against a peptide corresponding to amino acids 2-21 of schwannomin, was purchased from TEBU. Monoclonal antibodies were raised against the C-terminal domain of schwannomin by injecting mice with a purified GST fusion protein corresponding to amino acids 469-595 of schwannomin. Screening of the antibodies was performed using a histidine-tagged DHFR fusion protein corresponding to the same domain of schwannomin. The monoclonal antibodies were purified on protein G columns. One of them, monoclonal 22, was used for the detection of the Sch-∆Nter protein and for electron microscopy.
CTR433, a monoclonal antibody directed against the Golgi apparatus (31), was provided by M. Bornens. The monoclonal antibody OKT9, that reacts with the transferrin receptor (32) and the polyclonal antibody raised against the mannose 6-phosphate receptor (33) were supplied by A. Dautry and B. Hoflack, respectively, and were used as markers for endocytic compartments. The polyclonal antibody directed against the rough endoplasmic reticulum (34) was provided by D. Louvard. The anti-lamin B antibody (35) was supplied by J.-C. Courvalin. Monoclonal antibodies raised against the lysosomal protein lgp120 (Pharmingen), vimentin (DAKO), pancytokeratin (DAKO) and tubulin (Amersham) were also used. Rhodaminecoupled donkey anti-rabbit antibody and fluorescein-coupled sheep anti-mouse antibody were purchased from Amersham.
DNA constructs
Construct encoding wild-type schwannomin isoform 1 (SchIso1). Human schwannomin cDNA containing the complete coding sequence flanked by 24 and 133 bp of the 5′ and 3′ untranslated regions, respectively, was inserted in the EcoRI site of the eukaryotic expression vector pCB6 (36) . This insertion placed the schwannomin cDNA under the control of the cytomegalovirus promoter (construct Sch-Iso1). Iso1-Tag) . Site-directed mutagenesis of the HindIII site located at base pair 1487 was accomplished without modification of the coding properties of the sequence using the oligonucleotide (5′-GACATACCCAGCTTCAACC-3′) and the Transformert Site-Directed Mutagenesis Kit (Clontech). This allowed the use of the HindIII site located at base pair 864 of the schwannomin cDNA as a unique HindIII site. The cDNA encoding C-terminally tagged schwannomin was generated in two steps. First, the 5′ region was amplified with a forward primer including a KpnI site (5′-GGGGT-ACCCCTGAGCCCCGCGCCATG-3′) and a reverse primer overlapping the unique HindIII site at position 864 (5′-TTATTAACACGAAGCTTTGAGGAG-3′). Second, the 3′ region was amplified with a forward primer overlapping the unique HindIII site at position 864 (5′-GTTTAACTCCTC-AAAGCTTCGTG-3′) and a reverse primer including the VSV-G tag sequence and a XbaI site (5′-GCTCTAGATTTACTTGCCCA-GCCGGTTCATCTCGATTCGGTGTATGGGCCTGGAGGGC-CCTCCCGGGGGAGCTCTTCAAAGAAGGCCAC-3′). These PCR products were inserted into pBluescript KS + and the integrity of the amplified product was confirmed by sequencing. Finally, the entire tagged cDNA sequence was inserted into pCB6 eukaryotic expression vector to create the Sch-Iso1-Tag construct.
Construct encoding schwannomin isoform 1 tagged with VSV-G (Sch-
Constructs encoding the different tagged or untagged mutant cDNAs. Constructs encoding the various mutants of schwannomin were derived from Sch-Iso1 or Sch-Iso1-Tag by PCR using primers that overlap the mutation. Cloned PCR products were entirely resequenced to verify that no spurious mutation had been introduced during the PCR step. For the construct encoding the C-terminal domain of schwannomin isoform 1, the last 15 nucleotides of the 5′-untranslated region together with the three first codons were directly fused by PCR to position 752, corresponding to the codon of tyrosine 251.
Transient expression in HeLa cells
Exponentially growing HeLa cells were seeded 24 h before transfection. DNA transfer was performed following the procedure described by Chen and Okayama (37) . Briefly, cells were incubated overnight in the presence of calcium-phosphate DNA precipitate, washed with PBS, and fresh medium was then added. Cultures were analyzed for protein production after 24-30 h.
Immunoblotting
The transfected cells were washed with PBS and harvested by scraping directly into Laemmli sample buffer. Proteins were loaded onto a 10% polyacrylamide gel and separated under reducing conditions. Proteins were then electrotransferred onto nitrocellulose membrane (BioRad) and detected using the monoclonal anti-tag antibody or the polyclonal anti-Nter antibody. Detection was accomplished with horseradish peroxidase conjugated secondary antibodies (Amersham) and BM chemoluminescence blotting substrate (Boehringer Mannheim).
Indirect immunofluorescence
Transfected cells were fixed with 3% paraformaldehyde and permeabilized with 0.2% Triton X-100. Staining was performed in two sequential incubation steps. First, cells were incubated with the appropriate primary antibody depending upon the experiment. Then cells were incubated with the appropriate secondary fluorescent antibody, conjugated to either rhodamine or fluorescein.
For fluorescent double labeling of F-actin and schwannomin derived proteins, cells were incubated with a mixture of fluorescent phalloidin (conjugated to either rhodamine or fluorescein, 2 U per dish; Sigma) and the anti-tag antibody or the commercial anti-Nter antibody. Cells were mounted in Vectashield medium (Vector Laboratories) with DAPI (Sigma). Cells were examined with a Leica epifluorescence microscope or with a confocal Leica microscope.
Detergent extraction
Experiments were performed as described by Algrain et al. (30) .
Indirect immunofluorescence of detergent-extracted HeLa cells.
Cells on coverslips were washed with PBS, and dipped for 5 s in four different beakers each containing 30 ml of extraction buffer (50 mM MES, 3 mM EGTA, 5 mM MgCl 2 , 0.5% wt/vol Triton X-100, pH 6.4). Cells were then fixed with 3% paraformaldehyde and indirect immunofluorescence was performed.
Cell fractionation into detergent-soluble and detergent-insoluble material. HeLa transfected cells were extracted for 40 s with 300 µl of the extraction buffer described above. Detergentsoluble material was precipitated in 85% acetone for 4 h at -20_C and the pellet recovered after centrifugation. Detergent-insoluble material was scraped in PBS and then centrifuged. Pellets containing either the detergent-soluble or the detergent-insoluble material were resuspended in the same volume of Laemmli sample buffer. Equal amounts of each fraction were analyzed by immunoblotting.
Cytoskeleton assays
Cytochalasin D treatment. Transfected cells were treated with 2.5 µM cytochalasin D (Sigma) for 20 min at 37_C. After washing with PBS, cells were fixed with 3% paraformaldehyde.
Nocodazole treatment. Transfected cells were treated with 30 µM nocodazole (Sigma) for 5 min at 4_C, then transferred to 37_C for 30 min. After washing with PBS previously warmed to 37_C, cells were fixed with 3% paraformaldehyde at 37_C.
Electron microscopy
Transfected cells were fixed with 2% formaldehyde, 1% glutaraldehyde in 100 mM phosphate buffer pH 7.2. Cells were then embedded as a pellet in 7.5% gelatin. Ultra thin frozen sections were prepared according to Tokuyasu (38) on a RMC MT-7 cryoultramicrotome (Tucson). They were labeled with mono-clonal 22 combined with anti-mouse IgG antibodies conjugated to 10 nm gold particles (Biocell, used at OD = 0.15). Labeled sections were positively-negatively stained according to Griffiths et al. (39) and observed on a Jeol 1210 electron microscope.
ABBREVIATIONS
NF2, neurofibromatosis type 2; ERM, ezrin-radixin-moesin; GST, glutathione S-transferase; DHFR, dihydrofolate reductase; PCR, polymerase chain reaction; RT-PCR, reverse-transcriptase polymerase chain reaction; VSV-G, vesicular stomatitis virus glycoprotein G; PBS, phosphate buffered saline; F-actin, filamentous actin.
